Risk factors for osteoporosis in chronic inflammatory demyelinating polyradiculoneuropathy

Seung Woo Kim, Young Chul Choi, Seung Min Kim, Ha Young Shin

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Introduction: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) patients possess multiple risk factors for osteoporosis, but few studies have evaluated bone mineral density (BMD) in CIDP patients. Methods: We retrospectively compared the BMD of CIDP patients with that of normal controls, and evaluated the clinical factors associated with osteoporosis. Results: Total BMD was lower in CIDP patients than in normal controls (P = 0.017). In a comparison of 16 osteoporotic CIDP patients with 25 non-osteoporotic patients, the cumulative prednisolone dose was lower (P = 0.022) and the duration from disease onset to BMD measurement was shorter (P = 0.014) in osteoporotic patients than in non-osteoporotic patients. Function, as measured by modified Rankin scale score within 3 years of the BMD measurement, was worse in osteoporotic than in non-osteoporotic patients (P = 0.008). Discussion: BMD in CIDP patients was significantly lower than in normal controls. Functional status rather than cumulative steroid dose was associated with osteoporosis. Muscle Nerve 58: 407–412, 2018.

Original languageEnglish
Pages (from-to)407-412
Number of pages6
JournalMuscle and Nerve
Volume58
Issue number3
DOIs
Publication statusPublished - 2018 Sep

Fingerprint

Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Osteoporosis
Bone Density
Prednisolone
Steroids

All Science Journal Classification (ASJC) codes

  • Physiology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Physiology (medical)

Cite this

Kim, Seung Woo ; Choi, Young Chul ; Kim, Seung Min ; Shin, Ha Young. / Risk factors for osteoporosis in chronic inflammatory demyelinating polyradiculoneuropathy. In: Muscle and Nerve. 2018 ; Vol. 58, No. 3. pp. 407-412.
@article{bd4cb67a1b39442fb57bdc03b85b1903,
title = "Risk factors for osteoporosis in chronic inflammatory demyelinating polyradiculoneuropathy",
abstract = "Introduction: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) patients possess multiple risk factors for osteoporosis, but few studies have evaluated bone mineral density (BMD) in CIDP patients. Methods: We retrospectively compared the BMD of CIDP patients with that of normal controls, and evaluated the clinical factors associated with osteoporosis. Results: Total BMD was lower in CIDP patients than in normal controls (P = 0.017). In a comparison of 16 osteoporotic CIDP patients with 25 non-osteoporotic patients, the cumulative prednisolone dose was lower (P = 0.022) and the duration from disease onset to BMD measurement was shorter (P = 0.014) in osteoporotic patients than in non-osteoporotic patients. Function, as measured by modified Rankin scale score within 3 years of the BMD measurement, was worse in osteoporotic than in non-osteoporotic patients (P = 0.008). Discussion: BMD in CIDP patients was significantly lower than in normal controls. Functional status rather than cumulative steroid dose was associated with osteoporosis. Muscle Nerve 58: 407–412, 2018.",
author = "Kim, {Seung Woo} and Choi, {Young Chul} and Kim, {Seung Min} and Shin, {Ha Young}",
year = "2018",
month = "9",
doi = "10.1002/mus.26175",
language = "English",
volume = "58",
pages = "407--412",
journal = "Muscle and Nerve",
issn = "0148-639X",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

Risk factors for osteoporosis in chronic inflammatory demyelinating polyradiculoneuropathy. / Kim, Seung Woo; Choi, Young Chul; Kim, Seung Min; Shin, Ha Young.

In: Muscle and Nerve, Vol. 58, No. 3, 09.2018, p. 407-412.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Risk factors for osteoporosis in chronic inflammatory demyelinating polyradiculoneuropathy

AU - Kim, Seung Woo

AU - Choi, Young Chul

AU - Kim, Seung Min

AU - Shin, Ha Young

PY - 2018/9

Y1 - 2018/9

N2 - Introduction: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) patients possess multiple risk factors for osteoporosis, but few studies have evaluated bone mineral density (BMD) in CIDP patients. Methods: We retrospectively compared the BMD of CIDP patients with that of normal controls, and evaluated the clinical factors associated with osteoporosis. Results: Total BMD was lower in CIDP patients than in normal controls (P = 0.017). In a comparison of 16 osteoporotic CIDP patients with 25 non-osteoporotic patients, the cumulative prednisolone dose was lower (P = 0.022) and the duration from disease onset to BMD measurement was shorter (P = 0.014) in osteoporotic patients than in non-osteoporotic patients. Function, as measured by modified Rankin scale score within 3 years of the BMD measurement, was worse in osteoporotic than in non-osteoporotic patients (P = 0.008). Discussion: BMD in CIDP patients was significantly lower than in normal controls. Functional status rather than cumulative steroid dose was associated with osteoporosis. Muscle Nerve 58: 407–412, 2018.

AB - Introduction: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) patients possess multiple risk factors for osteoporosis, but few studies have evaluated bone mineral density (BMD) in CIDP patients. Methods: We retrospectively compared the BMD of CIDP patients with that of normal controls, and evaluated the clinical factors associated with osteoporosis. Results: Total BMD was lower in CIDP patients than in normal controls (P = 0.017). In a comparison of 16 osteoporotic CIDP patients with 25 non-osteoporotic patients, the cumulative prednisolone dose was lower (P = 0.022) and the duration from disease onset to BMD measurement was shorter (P = 0.014) in osteoporotic patients than in non-osteoporotic patients. Function, as measured by modified Rankin scale score within 3 years of the BMD measurement, was worse in osteoporotic than in non-osteoporotic patients (P = 0.008). Discussion: BMD in CIDP patients was significantly lower than in normal controls. Functional status rather than cumulative steroid dose was associated with osteoporosis. Muscle Nerve 58: 407–412, 2018.

UR - http://www.scopus.com/inward/record.url?scp=85053084288&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053084288&partnerID=8YFLogxK

U2 - 10.1002/mus.26175

DO - 10.1002/mus.26175

M3 - Article

C2 - 29896772

AN - SCOPUS:85053084288

VL - 58

SP - 407

EP - 412

JO - Muscle and Nerve

JF - Muscle and Nerve

SN - 0148-639X

IS - 3

ER -